The Latest Medical News

A Summary of The Latest Medical News: # New ACOG Guidelines May Help Change, Shorten Endometriosis Diagnosis Times The American College of Obstetricians & Gynecologists (ACOG) has released **Clinical Practice Guideline 11**, a significant update that provides the first comprehensive standard-of-care recommendations for diagnosing endometriosis[3]. This new guidance addresses a critical gap in patient care, as endometriosis diagnosis has traditionally taken between 4 and 11 years on average from symptom onset[3]. ## A Shift Away From Surgical Confirmation The most transformative change in the 2026 guidelines is the formal endorsement of **clinical diagnosis without requiring surgery**[1]. ACOG now recommends that a diagnosis made through symptom-based assessment and physical examination is sufficient to initiate medical treatment[1]. This represents a major departure from traditional approaches that relied heavily on laparoscopic surgery to confirm the condition. Previously, many patients were told that surgical confirmation was necessary. The new guidance encourages clinicians to begin empiric treatment earlier, potentially helping patients access relief sooner[2]. ## When To Suspect Endometriosis Clinicians should suspect endometriosis in patients presenting with cyclic or noncyclic signs including chronic pelvic pain, dysmenorrhea, deep dyspareunia, dysuria, or dyschezia[1]. Combined with patient history and physical examination findings, these symptoms can form the basis for a presumptive diagnosis[3]. ## Imaging Recommendations: A Clear Hierarchy **Transvaginal ultrasonography (TVUS) is recommended as the first-line imaging test** for suspected endometriosis[1][2]. This approach can help identify ovarian endometriomas ("chocolate cysts"), pelvic masses, and structural abnormalities[2]. If transvaginal ultrasound is not appropriate, transabdominal ultrasound may be used as an alternative[2]. For more complex or deep forms of the disease, **pelvic MRI may be recommended** to better map the extent of endometriosis before treatment planning[1][2]. ## Biomarkers Are Not Recommended ACOG strongly recommends against using biomarkers like CA 125 for diagnosis, citing their lack of accuracy compared to traditional clinical evaluation[1]. Blood tests, urine tests, and endometrial biomarkers currently lack sufficient accuracy and reliability for routine clinical diagnosis[2]. ## Benefits for Patients The updated approach aims to reduce the significant burden endometriosis places on patients. By enabling earlier clinical diagnosis, patients can begin treatment faster, potentially accessing needed relief and connecting with support resources sooner[3]. This is particularly important since while patients wait for diagnosis, they can experience disease progression, new symptoms, further decline in quality of life, and increasing healthcare costs[3]. Help with your insurance? https://tally.so/r/n012P9